{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T23:40:06Z","timestamp":1710632406421},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s12264-009-0909-0","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T03:43:41Z","timestamp":1254800621000},"page":"296-300","source":"Crossref","is-referenced-by-count":0,"title":["Potential pharmacological treatment of fragile X syndrome during adulthood","\u6210\u5e74\u8106\u6027X \u7efc\u5408\u75c7\u7684\u6f5c\u5728\u836f\u7269\u6cbb\u7597"],"prefix":"10.1007","volume":"25","author":[{"given":"Zhao-Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Gao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"5","key":"909_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","volume":"65","author":"A.J. Verkerk","year":"1991","unstructured":"Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65(5): 905\u2013914.","journal-title":"Cell"},{"issue":"1","key":"909_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(94)90232-1","volume":"77","author":"H. Siomi","year":"1994","unstructured":"Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 1994; 77(1): 33\u201339.","journal-title":"Cell"},{"issue":"5211","key":"909_CR3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.7732383","volume":"268","author":"Y. Feng","year":"1995","unstructured":"Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, et al. Translational suppression by trinucleotide repeat expansion at FMR1. Science 1995; 268(5211): 731\u2013734.","journal-title":"Science"},{"issue":"1","key":"909_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ng0994-88","volume":"8","author":"E.E. Eichler","year":"1994","unstructured":"Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, Thibodeau SN, et al. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 1994; 8(1): 88\u201394.","journal-title":"Nat Genet"},{"issue":"5010","key":"909_CR5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.252.5009.1097","volume":"252","author":"I. Oberle","year":"1991","unstructured":"Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991; 252(5010): 1097\u20131102.","journal-title":"Science"},{"issue":"3","key":"909_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0168-9525(03)00017-9","volume":"19","author":"R.F. Kooy","year":"2003","unstructured":"Kooy RF. Of mice and the fragile X syndrome. Trends Genet 2003; 19(3): 148\u2013154.","journal-title":"Trends Genet"},{"issue":"3","key":"909_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0968-0004(03)00033-1","volume":"28","author":"P. Jin","year":"2003","unstructured":"Jin P, Warren ST. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 2003; 28(3): 152\u2013158.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"909_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mrdd.20010","volume":"10","author":"R. Willemsen","year":"2004","unstructured":"Willemsen R, Oostra BA, Bassell GJ, Dictenberg J. The fragile X syndrome: from molecular genetics to neurobiology. Ment Retard Dev Disabil Res Rev 2004; 10(1): 60\u201367.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"1\u20132","key":"909_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-4328(00)00296-5","volume":"117","author":"D. Dam van","year":"2000","unstructured":"van Dam D, D\u2019Hooge R, Hauben E, Reyniers E, Gantois I, Bakker CE, et al. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res 2000; 117(1\u20132): 127\u2013136.","journal-title":"Behav Brain Res"},{"issue":"1","key":"909_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0306-4522(99)00285-7","volume":"94","author":"W. Paradee","year":"1999","unstructured":"Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neurosci 1999; 94(1): 185\u2013192.","journal-title":"Neurosci"},{"issue":"5","key":"909_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrn1667","volume":"6","author":"C. Bagni","year":"2005","unstructured":"Bagni C, Greenough WT. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 2005; 6(5): 376\u2013387.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"909_CR12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","volume":"27","author":"M.F. Bear","year":"2004","unstructured":"Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004; 27(7): 370\u2013377.","journal-title":"Trends Neurosci"},{"issue":"27","key":"909_CR13","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1523\/JNEUROSCI.1790-06.2006","volume":"26","author":"A.W. Grossman","year":"2006","unstructured":"Grossman AW, Aldridge GM, Weiler IJ, Greenough WT. Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci 2006; 26(27): 7151\u20137155.","journal-title":"J Neurosci"},{"issue":"41","key":"909_CR14","doi-asserted-by":"crossref","first-page":"9460","DOI":"10.1523\/JNEUROSCI.2638-05.2005","volume":"25","author":"J. Larson","year":"2005","unstructured":"Larson J, Jessen RE, Kim D, Fine AK, du Hoffmann J. Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J Neurosci 2005; 25(41): 9460\u20139469.","journal-title":"J Neurosci"},{"issue":"40","key":"909_CR15","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1523\/JNEUROSCI.2624-07.2007","volume":"27","author":"J.C. Lauterborn","year":"2007","unstructured":"Lauterborn JC, Rex CS, Kramar E, Chen LY, Pandyarajan V, Lynch G, et al. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 2007; 27(40): 10685\u201310694.","journal-title":"J Neurosci"},{"issue":"32","key":"909_CR16","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1523\/JNEUROSCI.1520-05.2005","volume":"25","author":"M.G. Zhao","year":"2005","unstructured":"Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci 2005; 25(32): 7385\u20137392.","journal-title":"J Neurosci"},{"issue":"2","key":"909_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0896-6273(00)80909-5","volume":"25","author":"P.T. Huerta","year":"2000","unstructured":"Huerta PT, Sun LD, Wilson MA, Tonegawa S. Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 2000; 25(2): 473\u2013480.","journal-title":"Neuron"},{"issue":"6407","key":"909_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"T.V. Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361(6407): 31\u201339.","journal-title":"Nature"},{"issue":"12","key":"909_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0166-2236(93)90197-T","volume":"16","author":"R.C. Malenka","year":"1993","unstructured":"Malenka RC, Nicoll RA. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci 1993;16(12): 521\u2013527.","journal-title":"Trends Neurosci"},{"issue":"8","key":"909_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0809-849","volume":"15","author":"D. Ehninger","year":"2009","unstructured":"Ehninger D, Silva AJ. Genetics and neuropsychiatric disorders: treatment during adulthood. Nat Med 2009; 15(8): 849\u2013850.","journal-title":"Nat Med"},{"issue":"6","key":"909_CR21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G. Dolen","year":"2007","unstructured":"Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al. Correction of fragile X syndrome in mice. Neuron 2007;56(6): 955\u2013962.","journal-title":"Neuron"},{"key":"909_CR22","doi-asserted-by":"crossref","unstructured":"Zeier Z, Kumar A, Bodhinathan K, Feller JA, Foster TC, Bloom DC. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Gene Ther 2009.","DOI":"10.1038\/gt.2009.83"},{"issue":"6","key":"909_CR23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1523\/JNEUROSCI.4880-03.2004","volume":"24","author":"J.D. Runyan","year":"2004","unstructured":"Runyan JD, Moore AN, Dash PK. A role for prefrontal cortex in memory storage for trace fear conditioning. J Neurosci 2004; 24(6): 1288\u20131295.","journal-title":"J Neurosci"},{"issue":"22","key":"909_CR24","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1073\/pnas.2132313100","volume":"100","author":"C.J. Han","year":"2003","unstructured":"Han CJ, O\u2019Tuathaigh CM, van Trigt L, Quinn JJ, Fanselow MS, Mongeau R, et al. Trace but not delay fear conditioning requires attention and the anterior cingulate cortex. Proc Natl Acad Sci U S A 2003; 100(22): 13087\u201313092.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"909_CR25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nn1101","volume":"6","author":"T. Blank","year":"2003","unstructured":"Blank T, Nijholt I, Kye MJ, Radulovic J, Spiess J. Small-conductance, Ca2+-activated K+ channel SK3 generates age-related memory and LTP deficits. Nat Neurosci 2003; 6(9): 911\u2013912.","journal-title":"Nat Neurosci"},{"issue":"10","key":"909_CR26","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1073\/pnas.0304544101","volume":"101","author":"V. Menon","year":"2004","unstructured":"Menon V, Leroux J, White CD, Reiss AL. Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression. Proc Natl Acad Sci U S A 2004; 101(10): 3615\u20133620.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5360","key":"909_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.280.5360.77","volume":"280","author":"R.E. Clark","year":"1998","unstructured":"Clark RE, Squire LR. Classical conditioning and brain systems: the role of awareness. Science 1998; 280(5360): 77\u201381.","journal-title":"Science"},{"issue":"5","key":"909_CR28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1542\/peds.95.5.744","volume":"95","author":"T.L. Baumgardner","year":"1995","unstructured":"Baumgardner TL, Reiss AL, Freund LS, Abrams MT. Specification of the neurobehavioral phenotype in males with fragile X syndrome. Pediatrics 1995; 95(5): 744\u2013752.","journal-title":"Pediatrics"},{"issue":"2","key":"909_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-0004.1984.tb00474.x","volume":"25","author":"J.P. Fryns","year":"1984","unstructured":"Fryns JP, Jacobs J, Kleczkowska A, van den Berghe H. The psychological profile of the fragile X syndrome. Clin Genet 1984; 25(2): 131\u2013134.","journal-title":"Clin Genet"},{"issue":"1","key":"909_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mrdd.20003","volume":"10","author":"K. Cornish","year":"2004","unstructured":"Cornish K, Sudhalter V, Turk J. Attention and language in fragile X. Ment Retard Dev Disabil Res Rev 2004; 10(1): 11\u201316.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"18","key":"909_CR31","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.5312-05.2006","volume":"26","author":"Y. Matsuda","year":"2006","unstructured":"Matsuda Y, Marzo A, Otani S. The presence of background dopamine signal converts long-term synaptic depression to potentiation in rat prefrontal cortex. J Neurosci 2006; 26(18): 4803\u20134810.","journal-title":"J Neurosci"},{"issue":"4","key":"909_CR32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuron.2006.02.002","volume":"49","author":"S.H. Snyder","year":"2006","unstructured":"Snyder SH. Dopamine receptor excess and mouse madness. Neuron 2006; 49(4): 484\u2013485.","journal-title":"Neuron"},{"issue":"Pt3","key":"909_CR33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1113\/jphysiol.2007.134502","volume":"581","author":"D.J. Surmeier","year":"2007","unstructured":"Surmeier DJ. Dopamine and working memory mechanisms in prefrontal cortex. J Physiol 2007; 581(Pt 3): 885.","journal-title":"J Physiol"},{"issue":"9","key":"909_CR34","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1073\/pnas.0308280101","volume":"101","author":"Y.Y. Huang","year":"2004","unstructured":"Huang YY, Simpson E, Kellendonk C, Kandel ER. Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc Natl Acad Sci U S A 2004; 101(9): 3236\u20133241.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"909_CR35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/A:1015556204669","volume":"21","author":"A. Carlsson","year":"2001","unstructured":"Carlsson A. A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture. Biosci Rep 2001;21(6): 691\u2013710.","journal-title":"Nobel lecture. Biosci Rep"},{"issue":"1","key":"909_CR36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1523\/JNEUROSCI.22-01-00294.2002","volume":"22","author":"A.R. West","year":"2002","unstructured":"West AR, Grace AA. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 2002; 22(1): 294\u2013304.","journal-title":"J Neurosci"},{"issue":"6541","key":"909_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/376572a0","volume":"376","author":"G.V. Williams","year":"1995","unstructured":"Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995;376(6541): 572\u2013575.","journal-title":"Nature"},{"issue":"32","key":"909_CR38","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1523\/JNEUROSCI.4603-04.2005","volume":"25","author":"X. Sun","year":"2005","unstructured":"Sun X, Zhao Y, Wolf ME. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci 2005; 25(32): 7342\u20137351.","journal-title":"J Neurosci"},{"issue":"22","key":"909_CR39","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1523\/JNEUROSCI.1021-04.2004","volume":"24","author":"K.Y. Tseng","year":"2004","unstructured":"Tseng KY, O\u2019Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 2004; 24(22): 5131\u20135139.","journal-title":"J Neurosci"},{"issue":"8","key":"909_CR40","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1073\/pnas.0308618100","volume":"101","author":"G. Chen","year":"2004","unstructured":"Chen G, Greengard P, Yan Z. Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Proc Natl Acad Sci U S A 2004; 101(8): 2596\u20132600.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"909_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.scitotenv.2007.03.027","volume":"381","author":"N. Li","year":"2007","unstructured":"Li N, Gao Z, Luo D, Tang X, Chen D, Hu Y. Selenium level in the environment and the population of Zhoukoudian area, Beijing, China. Sci Total Environ 2007; 381(1\u20133): 105\u2013111.","journal-title":"Sci Total Environ"},{"key":"909_CR42","doi-asserted-by":"crossref","unstructured":"Trantham-Davidson H, Neely LC, Lavin A, Seamans JK. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 2004; 24(47): 10652-10659.","DOI":"10.1523\/JNEUROSCI.3179-04.2004"},{"issue":"4","key":"909_CR43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","volume":"59","author":"H. Wang","year":"2008","unstructured":"Wang H, Wu LJ, Kim SS, Lee FJ, Gong B, Toyoda H, et al. FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 2008; 59(4): 634\u2013647.","journal-title":"Neuron"},{"issue":"7213","key":"909_CR44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/455607a","volume":"455","author":"D. Weinshenker","year":"2008","unstructured":"Weinshenker D, Warren ST. Neuroscience: fragile dopamine. Nature 2008; 455(7213): 607\u2013608.","journal-title":"Nature"},{"issue":"1","key":"909_CR45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","volume":"31","author":"F.M. Vrij de","year":"2008","unstructured":"de Vrij FM, Levenga J, van der Linde HC, Koekkoek SK, De Zeeuw CI, Nelson DL, et al. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 2008; 31(1): 127\u2013132.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"909_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","volume":"29","author":"E. Berry-Kravis","year":"2008","unstructured":"Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, et al. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 2008; 29(4): 293\u2013302.","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"909_CR47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","volume":"46","author":"E. Berry-Kravis","year":"2009","unstructured":"Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, et al. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 2009; 46(4): 266\u2013271.","journal-title":"J Med Genet"},{"issue":"9","key":"909_CR48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","volume":"24","author":"R.S. Jope","year":"2003","unstructured":"Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 2003; 24(9): 441\u2013443.","journal-title":"Trends Pharmacol Sci"},{"key":"909_CR49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","volume":"41","author":"C.J. Phiel","year":"2001","unstructured":"Phiel CJ, Klein PS. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001; 41: 789\u2013813.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"909_CR50","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","volume":"43","author":"P. Sarno De","year":"2002","unstructured":"De Sarno P, Li X, Jope RS. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 2002; 43(7): 1158\u20131164.","journal-title":"Neuropharmacology"},{"issue":"Pt7","key":"909_CR51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"B.W. Doble","year":"2003","unstructured":"Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci 2003; 116(Pt 7): 1175\u20131186.","journal-title":"J Cell Sci"},{"issue":"2","key":"909_CR52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cmdc.200500039","volume":"1","author":"A.P. Kozikowski","year":"2006","unstructured":"Kozikowski AP, Gaisina IN, Petukhov PA, Sridhar J, King LT, Blond SY, et al. Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson\u2019s disease. ChemMedChem 2006; 1(2): 256\u2013266.","journal-title":"ChemMedChem"},{"issue":"6","key":"909_CR53","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","volume":"45","author":"A. Martinez","year":"2002","unstructured":"Martinez A, Alonso M, Castro A, Perez C, Moreno FJ. First non- ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer\u2019s disease. J Med Chem 2002; 45(6): 1292\u20131299.","journal-title":"J Med Chem"},{"issue":"5","key":"909_CR54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","volume":"16","author":"E. Berry-Kravis","year":"2006","unstructured":"Berry-Kravis E, Krause SE, Block SS, Guter S, Wuu J, Leurgans S, et al. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol 2006; 16(5): 525\u2013540.","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-009-0909-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-009-0909-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-009-0909-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T23:17:32Z","timestamp":1710631052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-009-0909-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s12264-009-0909-0","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}